SE8501723L - Preparation att anvendas vid behandling av ledinflammation - Google Patents

Preparation att anvendas vid behandling av ledinflammation

Info

Publication number
SE8501723L
SE8501723L SE8501723A SE8501723A SE8501723L SE 8501723 L SE8501723 L SE 8501723L SE 8501723 A SE8501723 A SE 8501723A SE 8501723 A SE8501723 A SE 8501723A SE 8501723 L SE8501723 L SE 8501723L
Authority
SE
Sweden
Prior art keywords
pct
treatment
inflammation
led
preparation
Prior art date
Application number
SE8501723A
Other languages
English (en)
Other versions
SE8501723D0 (sv
Inventor
G T O Lindblad
Original Assignee
Pharmacia Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmacia Ab filed Critical Pharmacia Ab
Priority to SE8501723A priority Critical patent/SE8501723L/sv
Publication of SE8501723D0 publication Critical patent/SE8501723D0/sv
Priority to PCT/SE1986/000153 priority patent/WO1986005984A1/en
Priority to EP86902561A priority patent/EP0217914A1/en
Priority to JP61502298A priority patent/JPS62502472A/ja
Priority to US06/934,410 priority patent/US4801619A/en
Publication of SE8501723L publication Critical patent/SE8501723L/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
    • A61K31/728—Hyaluronic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
SE8501723A 1985-04-09 1985-04-09 Preparation att anvendas vid behandling av ledinflammation SE8501723L (sv)

Priority Applications (5)

Application Number Priority Date Filing Date Title
SE8501723A SE8501723L (sv) 1985-04-09 1985-04-09 Preparation att anvendas vid behandling av ledinflammation
PCT/SE1986/000153 WO1986005984A1 (en) 1985-04-09 1986-04-02 Hyaluronic acid preparation to be used for treating inflammations of skeletal joints
EP86902561A EP0217914A1 (en) 1985-04-09 1986-04-02 Hyaluronic acid preparation to be used for treating inflammations of skeletal joints
JP61502298A JPS62502472A (ja) 1985-04-09 1986-04-02 骨格関節の炎症の治療用製剤
US06/934,410 US4801619A (en) 1985-04-09 1986-04-02 Hyaluronic acid preparation to be used for treating inflammations of skeletal joints

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8501723A SE8501723L (sv) 1985-04-09 1985-04-09 Preparation att anvendas vid behandling av ledinflammation

Publications (2)

Publication Number Publication Date
SE8501723D0 SE8501723D0 (sv) 1985-04-09
SE8501723L true SE8501723L (sv) 1986-10-10

Family

ID=20359795

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8501723A SE8501723L (sv) 1985-04-09 1985-04-09 Preparation att anvendas vid behandling av ledinflammation

Country Status (5)

Country Link
US (1) US4801619A (sv)
EP (1) EP0217914A1 (sv)
JP (1) JPS62502472A (sv)
SE (1) SE8501723L (sv)
WO (1) WO1986005984A1 (sv)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4808576A (en) * 1986-04-28 1989-02-28 Mobay Corporation Remote administration of hyaluronic acid to mammals
US5079236A (en) * 1987-05-27 1992-01-07 Hyal Pharmaceutical Corporation Pure, sterile, pyrogen-free hyaluronic acid formulations their methods of preparation and methods of use
AU620821B2 (en) * 1987-08-25 1992-02-27 Macnaught Pty Limited Hyaluronic acid lubricating compounds
US5403592A (en) * 1987-08-25 1995-04-04 Macnaught Pty Limited Lubricant composition for rheumatism
IT1219587B (it) * 1988-05-13 1990-05-18 Fidia Farmaceutici Polisaccaridi carbossiilici autoreticolati
CA1340994C (en) 1989-09-21 2000-05-16 Rudolf Edgar Dr. Falk Treatment of conditions and disease
WO1991006303A1 (en) * 1989-10-27 1991-05-16 Case Western Reserve University Inhibition of cell growth by keratan sulfate, chondroitin sulfate, dermatan sulfate and other glycans
US5102783A (en) * 1990-01-12 1992-04-07 Vetrepharm, Inc. Composition and method for culturing and freezing cells and tissues
US5990096A (en) * 1990-09-18 1999-11-23 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061703C (en) * 1992-02-20 2002-07-02 Rudolf E. Falk Formulations containing hyaluronic acid
US5639738A (en) * 1992-02-20 1997-06-17 Hyal Pharmaceutical Corporation Treatment of basal cell carcinoma and actinic keratosis employing hyaluronic acid and NSAIDs
US5910489A (en) * 1990-09-18 1999-06-08 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5824658A (en) * 1990-09-18 1998-10-20 Hyal Pharmaceutical Corporation Topical composition containing hyaluronic acid and NSAIDS
US5605938A (en) * 1991-05-31 1997-02-25 Gliatech, Inc. Methods and compositions for inhibition of cell invasion and fibrosis using dextran sulfate
US5705178A (en) * 1991-05-31 1998-01-06 Gliatech, Inc. Methods and compositions based on inhibition of cell invasion and fibrosis by anionic polymers
US5234914A (en) * 1991-06-11 1993-08-10 Patent Biopharmaceutics, Inc. Methods of treating hemorrhoids and anorecial disease
US5792753A (en) * 1991-07-03 1998-08-11 Hyal Pharmaceutical Corporation Compositions comprising hyaluronic acid and prostaglandin-synthesis-inhibiting drugs
WO1994007505A1 (en) * 1991-07-03 1994-04-14 Norpharmco Inc. Use of hyaluronic acid and forms to prevent arterial restenosis
US6022866A (en) * 1991-07-03 2000-02-08 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US5977088A (en) * 1991-07-03 1999-11-02 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US6103704A (en) * 1991-07-03 2000-08-15 Hyal Pharmaceutical Corporation Therapeutic methods using hyaluronic acid
US5817644A (en) * 1991-07-03 1998-10-06 Hyal Pharmaceutical Corporation Targeting of dosages of medicine and therapeutic agents
US5990095A (en) * 1991-07-03 1999-11-23 Hyal Pharmaceutical Corporation Use of hyaluronic acid and forms to prevent arterial restenosis
US6218373B1 (en) 1992-02-20 2001-04-17 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
CA2061567C (en) * 1992-02-20 1998-02-03 Rudolf E. Falk Use of hyaluronic acid to repair ischemia reperfusion damage
US5942498A (en) * 1992-02-20 1999-08-24 Hyal Pharmaceutical Corporation Formulations containing hyaluronic acid
US5767106A (en) * 1992-02-21 1998-06-16 Hyal Pharmaceutical Corporation Treatment of disease and conditions associated with macrophage infiltration
US6114314A (en) * 1992-02-21 2000-09-05 Hyal Pharmaceutical Corp. Formulations containing hyaluronic acid
US5872094A (en) * 1993-01-06 1999-02-16 The General Hospital Corporation Method for attaching cartilaginous tissue, cartilage matrix protein or link protein to a surface
US6492349B1 (en) 1993-03-31 2002-12-10 Nutramax Laboratories, Inc. Aminosugar and glycosaminoglycan composition for the treatment and repair of connective tissue
US5364845C1 (en) * 1993-03-31 2002-09-10 Nutramax Lab Inc Glusosamine chondroitin and manganese composition for the protection and repair of connective tissue
US6541460B2 (en) 1996-08-07 2003-04-01 George D. Petito Method for use of hyaluronic acid in wound management
US6255295B1 (en) 1996-12-23 2001-07-03 Nutramax Laboratories, Inc. Aminosugar, glycosaminoglycan or glycosaminoglycan-like compounds, and s-adenosylmethionine composition for the protection, treatment, repair, and reduction of inflammation of connective tissue
RU2141828C1 (ru) * 1998-03-26 1999-11-27 ООО "Научно-исследовательский институт атеросклероза" (Медотель) Средство, пролонгирующее эффективность чесночного порошка
IT1302534B1 (it) 1998-12-21 2000-09-05 Fidia Advanced Biopolymers Srl Composizioni iniettabili, biocompatibili e biodegradabili comprendentialmeno un derivato dell'acido ialuronico, cellule condrogeniche, per
AU779400B2 (en) 1999-12-17 2005-01-20 Cartificial A/S A prosthetic device
US6608041B2 (en) 2000-02-18 2003-08-19 Milton Hammerly Analgesics combined with naturally-occurring chondroprotective agents
US6689399B1 (en) 2000-03-16 2004-02-10 James R. Dickson Transdermal delivery of an anti-inflammatory composition
DE10053053A1 (de) * 2000-10-19 2002-05-16 Knoell Hans Forschung Ev Pharmazeutische Formulierungen zur Hemmung von entzündlichen Arthritiden
NZ528544A (en) * 2001-03-29 2006-03-31 Scripps Research Inst Formulations comprising entrapped active ingredients and uses thereof
WO2003000190A2 (en) * 2001-06-25 2003-01-03 Depuy Liposomal encapsulation of glycosaminoglycans for the treatment of arthritic joints
MXPA01011542A (es) * 2001-11-13 2003-05-22 Alcon Inc Regeneracion del cartilago articular da°ado por la osteoartritis de grado i y ii, mediante la aplicacion intra-articular de una mezcla de hialuronato de sodio y de condroitin sulfato en un vehiculo de gel.
EP1480656A4 (en) * 2002-02-15 2007-07-18 Res Dev Foundation ADENOVIRAL TRANDUCTION INDUCED BY HYALURONIC ACID
EP1560588B1 (en) 2002-10-16 2011-09-21 ArthroDynamic Technologies, Animal Health Division, Inc. Treatment for traumatic synovitis and damaged articular cartilage
US7504387B2 (en) * 2002-10-16 2009-03-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan composition and method for treatment and prevention of interstitial cystitis
US7803787B2 (en) * 2002-10-16 2010-09-28 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage by transmucosal administration
US8455458B2 (en) 2002-10-16 2013-06-04 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treating connective tissue damage
US7485629B2 (en) * 2002-10-16 2009-02-03 Arthrodynamic Technologies, Animal Health Division, Inc. Composition and method for treatment of joint damage
US20080003258A1 (en) * 2002-10-16 2008-01-03 Marcum Frank D Composition and Method for Treating Rheumatoid Arthritis
RU2268052C2 (ru) * 2004-01-27 2006-01-20 Общество с ограниченной ответственностью Научно-производственное предприятие "Тульская индустрия ЛТД" Средство для лечения воспалительных и дегенеративных заболеваний суставов (варианты), способ лечения воспалительных и дегенеративных заболеваний суставов (варианты) и устройство для доставки лекарственного средства к пораженному участку
WO2006069452A1 (de) * 2004-12-28 2006-07-06 Mestex Ag Verwendung eines vanilloidrezeptoragonisten zusammen mit einem glycosaminoglycan oder proteoglycan für die herstellung eines mittels zur behandlung von gelenkschmerzen und verfahren zur applikation dieses mittels
WO2006073835A2 (en) * 2004-12-30 2006-07-13 Genzyme Corporation Regiments for intra-articular viscosupplementation
AU2006216802B2 (en) * 2005-02-22 2010-08-05 Merial Limited Methods for selectively treating COX-2 mediated disorders by administering gamma-tocopherol
CA2633978A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Bioabsorbable implant of hyaluronic acid derivative for treatment of osteochondral and chondral defects
CA2633957A1 (en) 2005-12-14 2007-06-21 Anika Therapeutics, Inc. Treatment of arthritis and other musculoskeletal disorders with crosslinked hyaluronic acid
US20070141160A1 (en) * 2005-12-15 2007-06-21 Brown Laura J Method of treatment for osteoarthritis by local intra-articular injection of microparticles
ES2621876T3 (es) * 2006-09-13 2017-07-05 Enhance Skin Products Inc. Composición cosmética para el tratamiento de la piel y procedimientos de la misma
US9186375B2 (en) 2007-06-21 2015-11-17 Arthrodynamic Technologies, Animal Health Division, Inc. Glycosaminoglycan compositions in combination with stem cells
US8506944B2 (en) 2008-05-07 2013-08-13 The Regents Of The University Of California Replenishment and enrichment of ocular surface lubrication
EP2915529B1 (en) 2008-05-07 2017-06-14 The Regents of The University of California Therapeutic replenishment and enrichment of ocular surface lubrication
GB201118586D0 (en) * 2011-10-27 2011-12-07 Turzi Antoine New A-PRP medical device, manufacturing machine and process
EP2886104A1 (en) 2013-12-11 2015-06-24 Patir, Suleyman An intra-articular gel
US12440835B2 (en) 2019-01-21 2025-10-14 Vias Partners, Llc Methods, systems and apparatus for separating components of a biological sample
KR20220091580A (ko) 2019-10-31 2022-06-30 이클립스 메드코프 엘엘씨 샘플의 구성요소들을 분리하기 위한 시스템, 방법 및 장치

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT252264B (de) * 1965-03-17 1967-02-10 Etapharm Chem Pharm Lab Ges M Verfahren zur Herstellung eines reinen hochviskosen Hyaluronsäurepräparates
US4141973A (en) * 1975-10-17 1979-02-27 Biotrics, Inc. Ultrapure hyaluronic acid and the use thereof
US4328803B1 (en) * 1980-10-20 1994-01-11 Opthalmic Systems, Inc. Opthalmological procedures
JPS5837001A (ja) * 1981-08-27 1983-03-04 Green Cross Corp:The ヒアルロン酸の製造法
US4517295A (en) * 1983-02-18 1985-05-14 Diagnostic, Inc. Hyaluronic acid from bacterial culture
FR2553099B1 (fr) * 1983-10-11 1989-09-08 Fidia Spa Fractions d'acide hyaluronique ayant une activite pharmaceutique, procedes pour leur preparation et compositions pharmaceutiques les contenant
NO160722C (no) * 1983-11-25 1989-05-24 Miles Inc Fremgangsmaate for fremstilling av ultraren hyaluronsyre.
NO161573C (no) * 1983-11-25 1989-08-30 Miles Inc Fremgangsmaate til fremstilling av hyaluronsyre.

Also Published As

Publication number Publication date
WO1986005984A1 (en) 1986-10-23
JPS62502472A (ja) 1987-09-24
US4801619A (en) 1989-01-31
EP0217914A1 (en) 1987-04-15
SE8501723D0 (sv) 1985-04-09

Similar Documents

Publication Publication Date Title
SE8501723L (sv) Preparation att anvendas vid behandling av ledinflammation
ES2075202T3 (es) Nuevas arilpiridazinas, su preparacion, su utilizacion, y medicamentos que las contienen.
GR3018157T3 (en) Amphoteric compositions and polymeric forms of alpha hydroxyacids, and their therapeutic use.
MX168000B (es) Complemento dietetico que contiene beta-glucan complemento
SE8300598D0 (sv) Stabilized insulin solutions and method for their production
DE69524772D1 (de) Ophthalmologisches abgabesystem
ES2086644T3 (es) Preparado anovulatorio para la contracepcion hormonal.
IL81147A0 (en) Low viscosity high molecular weight,filter sterilizable hyaluronic acid and its preparation
PT1337236E (pt) Suplemento a ser administrado entericamente para alimentacao parenterica ou paraalimentacao parcial enterica/ oral de doentes em estado critico, doentes cronicos e de pessoas mal nutridas
DE3484997D1 (de) Zellstimulierendes mittel.
SE8405464L (sv) Komposition for oftalmologiska applikationer
EP0126523A3 (en) Dentifrice compostions
ATE183075T1 (de) Retinoid enthaltendes mittel
TR200002078T2 (tr) Sentetik polisakkaridler, hazırlanmaları için proses ve bunları içeren farmasötik kompozisyonlar.
MX9203374A (es) Composicion farmaceutica que contiene l-alfa-glicerofosforilcolina.
MX9701609A (es) Composicion espesada por un alquileter de polisacarido.
ID15895A (id) Formulasi untuk menurunkan kolesterol darah dan penyerapan lemak berbagai fungsi
MY103079A (en) New ophtalmological composition of matter
FI942361A0 (sv) Förfarande och arrangemang i samband med bilskärmar, för att minska växelströmsfältet i bildskärmens omgivning
FR2396019A1 (fr) Nouveaux glycopeptides acetyles hydrosolubles extraits de corps microbiens lyses de pseudomonas aeruginosa, procede de preparation et application a titre de medicaments
ATE130628T1 (de) Antioxydantsystem auf basis einer basischen aminosäure und eines tocopherols.
KR880009656A (ko) 국소 치근막 질환의 치료 또는 예방법
ATE45373T1 (de) Zusatzmittel enthaltende anstriche.
ES2163450T3 (es) Utilizacion de benzidamina en el tratamiento de estados patologicos causados por tnf.
SE9003181D0 (sv) Use of heparin fraction